BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9725809)

  • 1. Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagon infusion.
    McGuinness OP; Ejiofor J; Audoly LP; Schrom N
    Am J Physiol; 1998 Sep; 275(3):E432-9. PubMed ID: 9725809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Chu CA; Rohlie M; Neal DW; Swift LL; Cherrington AD
    Diabetes; 1997 Feb; 46(2):187-96. PubMed ID: 9000693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
    Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
    Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal adrenergic blockade does not inhibit the gluconeogenic effects of circulating catecholamines on the liver.
    Chu CA; Sindelar DK; Neal DW; Cherrington AD
    Metabolism; 1997 Apr; 46(4):458-65. PubMed ID: 9109855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN.
    Donmoyer CM; Chen SS; Hande SA; Lacy DB; Ejiofor J; McGuinness OP
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E235-43. PubMed ID: 10913021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
    Hendrick GK; Frizzell RT; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work.
    Wasserman DH; Spalding JA; Lacy DB; Colburn CA; Goldstein RE; Cherrington AD
    Am J Physiol; 1989 Jul; 257(1 Pt 1):E108-17. PubMed ID: 2665514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct effects of catecholamines on hepatic glucose production in conscious dog are due to glycogenolysis.
    Chu CA; Sindelar DK; Neal DW; Cherrington AD
    Am J Physiol; 1996 Jul; 271(1 Pt 1):E127-37. PubMed ID: 8760090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog.
    Connolly CC; Adkins-Marshall BA; Neal DW; Pugh W; Jaspan JB; Cherrington AD
    Diabetes; 1992 Oct; 41(10):1308-19. PubMed ID: 1397705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chronic fructose infusion on hepatic metabolism during TPN administration.
    Donmoyer CM; Lacy DB; Zhang Y; Chen SS; McGuinness OP
    Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1151-8. PubMed ID: 12424103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs.
    Shiota M; Jackson PA; Bischoff H; McCaleb M; Scott M; Monohan M; Neal DW; Cherrington AD
    Am J Physiol; 1997 Nov; 273(5):E868-79. PubMed ID: 9374671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dog.
    Connolly CC; Ivy RE; Adkins-Marshall BA; Dobbins RL; Neal DW; Williams PE; Cherrington AD
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):45-56. PubMed ID: 8792101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin.
    Camacho RC; Pencek RR; Lacy DB; James FD; Wasserman DH
    Diabetes; 2004 Feb; 53(2):285-93. PubMed ID: 14747277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglucagonemia and hepatic glucose metabolism during infection in the conscious dog.
    McGuinness OP; Lacy DB; Eliasson K
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E580-8. PubMed ID: 8928762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
    McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD
    Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of exercise-induced increase in hepatic glucose production to glucose supply and demand.
    Berger CM; Sharis PJ; Bracy DP; Lacy DB; Wasserman DH
    Am J Physiol; 1994 Sep; 267(3 Pt 1):E411-21. PubMed ID: 7943221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in hepatic gluconeogenic amino acid uptake and gluconeogenesis in the endotoxin treated conscious dog.
    Meinz H; Lacy DB; Ejiofor J; McGuinness OP
    Shock; 1998 Apr; 9(4):296-303. PubMed ID: 9565259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonesterified fatty acids and hepatic glucose metabolism in the conscious dog.
    Moore MC; Satake S; Lautz M; Soleimanpour SA; Neal DW; Smith M; Cherrington AD
    Diabetes; 2004 Jan; 53(1):32-40. PubMed ID: 14693695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.